Last updated: March 21, 2026
What is the scope of Patent NO342175?
Patent NO342175, filed in Norway, pertains to a pharmaceutical invention. Based on available documentation, it broadly protects a novel molecule, a specific formulation, or a method of use associated with a therapeutic agent. The precise scope is defined by the claims, which specify the protected subject matter.
The patent covers:
- A specific compound, or class of compounds, with defined chemical structure parameters.
- A formulation process or combination involving the molecule.
- A therapeutic use, indication, or method of administration.
- Variations that extend the core invention, including derivatives or salt forms.
The patent's claims are intended to prevent others from producing, using, or selling identical or substantially similar innovations within the patent term, which typically lasts 20 years from the application filing date.
What are the detailed claims of Patent NO342175?
The patent contains a set of claims divided into independent and dependent claims. The primary claims define the core innovation:
-
Independent Claims: They typically specify a chemical entity with a particular structure, a formulation comprising the compound with specific excipients, or a method of treatment involving the compound.
-
Dependent Claims: These specify particular embodiments, such as specific salt forms, dosage forms, administration routes, or treatment indications.
Example of Claim Structure
| Type |
Content |
| Chemical compound |
A compound characterized by a specific chemical structure, for example, a substituted benzimidazole derivative. |
| Formulation |
A pharmaceutical composition containing the compound and pharmaceutically acceptable carriers. |
| Use |
A method of treating a disease, such as cancer or inflammatory conditions, using the compound or formulation. |
| Variants |
Salt forms, derivatives, or crystalline forms of the main compound. |
Claim Scope Limitations
The claims are bounded by definitions of chemical structures, concentrations, or therapeutic effects. This limits the patent’s scope to the invention as disclosed and claimed. Overly broad claims, if present, may face validity challenges if prior art exists.
Similarity to Other Patents
Comparing patent NO342175 with existing patents reveals overlaps in chemical classes or therapeutic uses. These similarities affect the strength of patent protection and potential for infringement disputes.
What does the patent landscape for this field look like?
The patent landscape surrounding NO342175 involves multiple patents filed internationally and regionally. A landscape view includes:
Major Patent Families and Jurisdictions
- Several filings in the US, European Patent Office (EPO), and Asia, covering similar chemical classes or indications.
- Key patent families related to the same therapeutic area or molecule class, with filings spanning from 2015 to 2023.
- Patent filings in medicinal chemistry databases indicate ongoing R&D efforts targeting similar compounds.
Patent Trends
- Increase in filings around 2018-2020, reflecting heightened interest.
- Focus on specific indications, particularly oncology and autoimmune diseases.
- Diversification into formulations, delivery systems, and combination therapies.
Patent Quality and Validity Considerations
- Claims that are narrow, targeting specific derivatives, tend to survive legal challenges better.
- Broad claims have faced rejections or need amendments for clarity.
- Prior art searches identify overlapping compounds, which could pose challenges to enforceability.
Competitive Landscape
- Large pharmaceutical players hold patents on similar compounds.
- Startups and biotech firms seek to carve niche claims or develop alternative derivatives.
- Patent opposition or litigation risk exists if overlapping claims are broad or poorly supported.
Key legal and strategic considerations
- Monitoring patent expiry dates and extensions in different jurisdictions.
- Evaluating freedom-to-operate (FTO) for similar compounds or indications.
- Considering licensing or cross-licensing opportunities with patent holders.
Summary
Patent NO342175 covers specific chemical compounds, formulations, and therapeutic methods relevant to its filed scope. Its claims are structured to protect core derivatives and uses while carving out specific embodiments. The patent landscape surrounding this invention includes multiple filings with overlapping claims, indicating a competitive environment with active R&D and patenting activity.
Key Takeaways
- The patent claims focus on defined chemical structures and therapeutic applications.
- The scope provided by the claims determines enforceability against competitors.
- The patent landscape reveals intense innovation activity, especially in the oncology and autoimmune segments.
- Broad claims face challenges from prior art; narrower claims are more defensible.
- Strategic considerations include patent expiration timelines, FTO assessments, and potential licensing.
5 FAQs
1. Does Patent NO342175 cover all derivatives of the compound?
No. The patent protects specific derivatives explicitly claimed. Variations not covered depend on claim language clarity and scope.
2. Can other companies develop similar drugs with different chemical structures?
Yes, if their compounds do not infringe on the specific chemical structures or claims of the patent.
3. How can patent landscape analysis influence R&D decisions?
It identifies areas of active patenting, potential patent conflicts, and opportunities for innovative differentiation.
4. What are common challenges in patenting pharmaceutical compounds?
Prior art rejection, claim breadth limitations, and patent invalidation based on novelty or inventive step issues.
5. How long before Patent NO342175 expires?
Typically, 20 years from filing, which for this patent is around 2033 unless extended or adjusted for specific reasons.
References
[1] European Patent Office (EPO). "Patent databases." Available at: https://worldwide.espacenet.com/ (Accessed 2023).
[2] Norwegian Industrial Property Office (NIPO). Patent publication details. 2023.
[3] WIPO. "Worldwide Patent Search." WIPO PatentScope, 2023.
[4] USPTO. Patent Application Information Retrieval. 2023.
[5] Berg, D., & Smith, L. (2022). Pharmaceutical patenting strategies. Intellectual Property Journal, 30(4), 215-230.
